ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Mutational Testing in mCRC: Methods and Data Driving Treatment Selection "
Episode Synopsis
Host: Fortunato Ciardiello, MD, PhD
Host: Jenny Seligmann, MBChB, PhD
This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant mCRC, and the management of treatment-related adverse events.
In God we trust